FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Hoedemaeker

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Anatomy

Geographic Areas

Co-author Network

Publications

TOP 3
Celine H M Leenen; Judith de Waard; Winand N M Dinjens; Hendrikus J Dubbink; Robert F Hoedemaeker; Sanne M Hulspas; Sjarlot G Kooi; Ernst J Kuipers; Ans M W van den Ouweland; Helena C van Doorn; Monique E van Leerdam; Margot G F van Lier; Anja Wagner; Ewout W Steyerberg
Prospective evaluation of molecular screening for Lynch syndrome in patients with endometrial cancer ≤ 70 years.
Tineke Wolters; Geert J L H van Leenders; Pim J van Leeuwen; Robert F Hoedemaeker; Roberta Mazzucchelli; Rodolfo Montironi; Monique J Roobol; Marina Scarpelli; Fritz H Schröder; Roderick C N van den Bergh; Theodorus H van der Kwast
Comparison of incidentally detected prostate cancer with screen-detected prostate cancer treated by prostatectomy.
Tineke Wolters; Monique J Roobol; Pim J van Leeuwen; Roderick C N van den Bergh; Robert F Hoedemaeker; Geert J L H van Leenders; Fritz H Schröder; Theodorus H van der Kwast
A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Hoedemaeker (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Celine H M Leenen; Judith de Waard; Winand N M Dinjens; Hendrikus J Dubbink; Robert F Hoedemaeker; Sanne M Hulspas; Sjarlot G Kooi; Ernst J Kuipers; Ans M W van den Ouweland; Helena C van Doorn; Monique E van Leerdam; Margot G F van Lier; Anja Wagner; Ewout W Steyerberg
Prospective evaluation of molecular screening for Lynch syndrome in patients with endometrial cancer ≤ 70 years.
Gynecologic oncology 2012;125(2):414-20.
2012: Tineke Wolters; Geert J L H van Leenders; Pim J van Leeuwen; Robert F Hoedemaeker; Roberta Mazzucchelli; Rodolfo Montironi; Monique J Roobol; Marina Scarpelli; Fritz H Schröder; Roderick C N van den Bergh; Theodorus H van der Kwast
Comparison of incidentally detected prostate cancer with screen-detected prostate cancer treated by prostatectomy.
The Prostate 2012;72(1):108-15.
2011: Tineke Wolters; Monique J Roobol; Pim J van Leeuwen; Roderick C N van den Bergh; Robert F Hoedemaeker; Geert J L H van Leenders; Fritz H Schröder; Theodorus H van der Kwast
A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial.
The Journal of urology 2011;185(1):121-5.
2010: Tineke Wolters; Monique J Roobol; Pim J van Leeuwen; Roderick C N van den Bergh; Robert F Hoedemaeker; Geert J L H van Leenders; Fritz H Schröder; Theo Van der Kwast
Should pathologists routinely report prostate tumour volume? The prognostic value of tumour volume in prostate cancer.
European urology 2010;57(5):821-9.
2007: Renske Postma; Fritz H Schröder; Geert J L H van Leenders; Robert F Hoedemaeker; André N Vis; Monique J Roobol; Theo Van der Kwast
Cancer detection and cancer characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC)--Section Rotterdam. A comparison of two rounds of screening.
European urology 2007;52(1):89-97.
2005: Theo Van der Kwast; Renske Postma; Robert F Hoedemaeker; Geert J L H van Leenders; Fritz H Schröder
Features of prostate cancers detected during a prevalence screening round. The Rotterdam experience.
The Canadian journal of urology 2005;12 Suppl 2():16-20.
2003: Theo Van der Kwast; Monique J Roobol; Mark F Wildhagen; Paula M Martikainen; L Määtänen; Carl-Gustaf Pihl; Carlos Santonja; L Bubendorf; Ingrid Neetens; Simonetta Di Lollo; Robert F Hoedemaeker
Consistency of prostate cancer grading results in screened populations across Europe.
BJU international 2003;92 Suppl 2():88-91.
2003: Robert F Hoedemaeker; Theo Van der Kwast; Fritz H Schröder
The clinical significance of a small focus of well-differentiated carcinoma at prostate biopsy.
BJU international 2003;92 Suppl 2():92-6.
2003: Theo Van der Kwast; C Lopes; Paula M Martikainen; Carl-Gustaf Pihl; Carlos Santonja; Ingrid Neetens; Simonetta Di Lollo; Robert F Hoedemaeker
Report of the Pathology Committee: false-positive and false-negative diagnoses of prostate cancer.
BJU international 2003;92 Suppl 2():62-5.
2003: Herman van Dekken; Janneke C Alers; Irma A A J Damen; Kees J Vissers; Pieter-Jaap Krijtenburg; Robert F Hoedemaeker; Mark F Wildhagen; Wim C J Hop; Theo Van der Kwast; Hans J Tanke; Fritz H Schröder
Genetic evaluation of localized prostate cancer in a cohort of forty patients: gain of distal 8q discriminates between progressors and nonprogressors.
Laboratory investigation; a journal of technical methods and pathology 2003;83(6):789-96.
2003: Theo Van der Kwast; C Lopes; Carlos Santonja; Carl-Gustaf Pihl; Ingrid Neetens; P Martikainen; Simonetta Di Lollo; L Bubendorf; Robert F Hoedemaeker
Guidelines for processing and reporting of prostatic needle biopsies.
Journal of clinical pathology 2003;56(5):336-40.
2001: André N Vis; Robert F Hoedemaeker; Monique J Roobol; Fritz H Schröder; Theo Van der Kwast
The predictive value for prostate cancer of lesions that raise suspicion of concomitant carcinoma: an evaluation from a randomized, population-based study of screening for prostate cancer.
Cancer 2001;92(3):524-34.
2001: Robert F Hoedemaeker; Theo Van der Kwast; Rob Boer; Harry J de Koning; Monique J Roobol; André N Vis; Fritz H Schröder
Pathologic features of prostate cancer found at population-based screening with a four-year interval.
Journal of the National Cancer Institute 2001;93(15):1153-8.
2001: André N Vis; Robert F Hoedemaeker; Monique J Roobol; Theo Van der Kwast; Fritz H Schröder
Tumor characteristics in screening for prostate cancer with and without rectal examination as an initial screening test at low PSA (0.0-3.9 ng/ml).
The Prostate 2001;47(4):252-61.
2001: André N Vis; Robert F Hoedemaeker; Theo Van der Kwast; Fritz H Schröder
Defining the window of opportunity in screening for prostate cancer: validation of a predictive tumor classification model.
The Prostate 2001;46(2):154-62.
2001: Janneke C Alers; Pieter-Jaap Krijtenburg; André N Vis; Robert F Hoedemaeker; Mark F Wildhagen; Wim C J Hop; T T van Der Kwast; Fritz H Schröder; Hans J Tanke; Herman van Dekken
Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies : early cancers may contain aggressive genetic features.
The American journal of pathology 2001;158(2):399-406.
2000: Robert F Hoedemaeker; André N Vis; Theo Van der Kwast
Staging prostate cancer.
Microscopy research and technique 2000;51(5):423-9.
2000: Robert F Hoedemaeker
Current topics in prostate cancer research.
Microscopy research and technique 2000;51(5):413-4.
2000: André N Vis; M O Boerma; Stefano Ciatto; Robert F Hoedemaeker; Fritz H Schröder; Theo Van der Kwast
Detection of prostate cancer: a comparative study of the diagnostic efficacy of sextant transrectal versus sextant transperineal biopsy.
Urology 2000;56(4):617-21.
2000: Robert F Hoedemaeker; JB Rietbergen; Ries Kranse; Fritz H Schröder; Theo Van der Kwast
Histopathological prostate cancer characteristics at radical prostatectomy after population based screening.
The Journal of urology 2000;164(2):411-5.
2000: Fritz H Schröder; Ingrid W van der Cruijsen-Koeter; Harry J de Koning; André N Vis; Robert F Hoedemaeker; Ries Kranse
Prostate cancer detection at low prostate specific antigen.
The Journal of urology 2000;163(3):806-12.
1999: JB Rietbergen; Robert F Hoedemaeker; AE Kruger; Wim J Kirkels; Fritz H Schröder
The changing pattern of prostate cancer at the time of diagnosis: characteristics of screen detected prostate cancer in a population based screening study.
The Journal of urology 1999;161(4):1192-8.
1999: Hendrikus J Dubbink; Robert F Hoedemaeker; Theo Van der Kwast; Fritz H Schröder; Johannes C Romijn
Human prostate-specific transglutaminase: a new prostatic marker with a unique distribution pattern.
Laboratory investigation; a journal of technical methods and pathology 1999;79(2):141-50.
1999: Robert F Hoedemaeker; Ries Kranse; JB Rietbergen; AE Kruger; Fritz H Schröder; Theo Van der Kwast
Evaluation of prostate needle biopsies in a population-based screening study: the impact of borderline lesions.
Cancer 1999;85(1):145-52.
1998: Fritz H Schröder; Paul J van der Maas; PM Beemsterboer; A B Kruger; Robert F Hoedemaeker; JB Rietbergen; Ries Kranse
Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
Journal of the National Cancer Institute 1998;90(23):1817-23.
1998: JB Rietbergen; AE Kruger; Robert F Hoedemaeker; Chris H Bangma; Wim J Kirkels; Fritz H Schröder
Repeat screening for prostate cancer after 1-year followup in 984 biopsied men: clinical and pathological features of detected cancer.
The Journal of urology 1998;160(6 Pt 1):2121-5.
1998: Adriaan B Houtsmuller; P J Janssen; Alex L Nigg; Robert F Hoedemaeker; Theo Van der Kwast
Quantitative immunohistochemistry of androgen receptors in a microsphere model system and in prostate tissue sections.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1998;20(5):365-72.
1998: JB Rietbergen; Ries Kranse; Robert F Hoedemaeker; AE Kruger; Chris H Bangma; Wim J Kirkels; Fritz H Schröder
Comparison of prostate-specific antigen corrected for total prostate volume and transition zone volume in a population-based screening study.
Urology 1998;52(2):237-46.
1997: Robert F Hoedemaeker; JB Rietbergen; Ries Kranse; Theo Van der Kwast; Fritz H Schröder
Comparison of pathologic characteristics of T1c and non-T1c cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate Cancer.
World journal of urology 1997;15(6):339-45.